MOLINA HEALTHCARE INC (MOH)
US60855R1005 - Common Stock
Taking everything into account, MOH scores 6 out of 10 in our fundamental rating. MOH was compared to 117 industry peers in the Health Care Providers & Services industry. While MOH has a great health rating, its profitability is only average at the moment. MOH has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year MOH was profitable.
In the past year MOH had a positive cash flow from operations.
MOH had positive earnings in each of the past 5 years.
MOH had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of MOH (6.90%) is better than 90.52% of its industry peers.
With an excellent Return On Equity value of 23.84%, MOH belongs to the best of the industry, outperforming 91.38% of the companies in the same industry.
MOH has a better Return On Invested Capital (17.23%) than 94.83% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MOH is significantly above the industry average of 8.59%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.9% | ||
| ROE | 23.84% | ||
| ROIC | 17.23% |
ROA(3y)6.39%
ROA(5y)7.41%
ROE(3y)25.89%
ROE(5y)29.47%
ROIC(3y)17.87%
ROIC(5y)18.84%
1.3 Margins
The Profit Margin of MOH (2.99%) is better than 74.14% of its industry peers.
In the last couple of years the Profit Margin of MOH has declined.
MOH's Operating Margin of 4.51% is fine compared to the rest of the industry. MOH outperforms 63.79% of its industry peers.
MOH's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 15.74%, MOH is doing worse than 69.83% of the companies in the same industry.
MOH's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.51% | ||
| PM (TTM) | 2.99% | ||
| GM | 15.74% |
OM growth 3Y-6.48%
OM growth 5Y-5.57%
PM growth 3Y-2.6%
PM growth 5Y-3.07%
GM growth 3Y-5.09%
GM growth 5Y-2.44%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MOH is creating value.
MOH has about the same amout of shares outstanding than it did 1 year ago.
MOH has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, MOH has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 4.45 indicates that MOH is not in any danger for bankruptcy at the moment.
MOH has a Altman-Z score of 4.45. This is amongst the best in the industry. MOH outperforms 84.48% of its industry peers.
The Debt to FCF ratio of MOH is 2.70, which is a good value as it means it would take MOH, 2.70 years of fcf income to pay off all of its debts.
MOH's Debt to FCF ratio of 2.70 is amongst the best of the industry. MOH outperforms 81.90% of its industry peers.
A Debt/Equity ratio of 0.53 indicates that MOH is somewhat dependend on debt financing.
MOH has a Debt to Equity ratio (0.53) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 2.7 | ||
| Altman-Z | 4.45 |
ROIC/WACC2
WACC8.63%
2.3 Liquidity
A Current Ratio of 1.49 indicates that MOH should not have too much problems paying its short term obligations.
MOH has a Current ratio of 1.49. This is comparable to the rest of the industry: MOH outperforms 57.76% of its industry peers.
MOH has a Quick Ratio of 1.49. This is a normal value and indicates that MOH is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.49, MOH is doing good in the industry, outperforming 63.79% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.49 | ||
| Quick Ratio | 1.49 |
3. Growth
3.1 Past
MOH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.57%, which is quite good.
The Earnings Per Share has been growing by 15.81% on average over the past years. This is quite good.
MOH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.82%.
Measured over the past years, MOH shows a quite strong growth in Revenue. The Revenue has been growing by 12.52% on average per year.
EPS 1Y (TTM)10.57%
EPS 3Y25.14%
EPS 5Y15.81%
EPS growth Q2Q-1.38%
Revenue 1Y (TTM)10.82%
Revenue growth 3Y20.6%
Revenue growth 5Y12.52%
Revenue growth Q2Q21.87%
3.2 Future
MOH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.59% yearly.
MOH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.11% yearly.
EPS Next Y14.42%
EPS Next 2Y14.39%
EPS Next 3Y14.59%
EPS Next 5YN/A
Revenue Next Year17.88%
Revenue Next 2Y12.9%
Revenue Next 3Y11.11%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 16.28, which indicates a correct valuation of MOH.
80.17% of the companies in the same industry are more expensive than MOH, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 24.67. MOH is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 12.39, the valuation of MOH can be described as correct.
Based on the Price/Forward Earnings ratio, MOH is valued cheaper than 87.93% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of MOH to the average of the S&P500 Index (21.02), we can say MOH is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.28 | ||
| Fwd PE | 12.39 |
4.2 Price Multiples
MOH's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. MOH is cheaper than 97.41% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MOH indicates a somewhat cheap valuation: MOH is cheaper than 70.69% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.53 | ||
| EV/EBITDA | 5.06 |
4.3 Compensation for Growth
MOH's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of MOH may justify a higher PE ratio.
MOH's earnings are expected to grow with 14.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.13
PEG (5Y)1.03
EPS Next 2Y14.39%
EPS Next 3Y14.59%
5. Dividend
5.1 Amount
No dividends for MOH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
MOLINA HEALTHCARE INC
NYSE:MOH (5/1/2024, 1:15:49 PM)
338.79
-3.31 (-0.97%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap19.85B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.28 | ||
| Fwd PE | 12.39 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.13
PEG (5Y)1.03
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.9% | ||
| ROE | 23.84% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 4.51% | ||
| PM (TTM) | 2.99% | ||
| GM | 15.74% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2.31
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.49 | ||
| Quick Ratio | 1.49 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)10.57%
EPS 3Y25.14%
EPS 5Y
EPS growth Q2Q
EPS Next Y14.42%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)10.82%
Revenue growth 3Y20.6%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y